---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-093964"
form_type: "8-K"
ticker: "ELOX"
cik: "0001035354"
company_name: "Eloxx Pharmaceuticals, Inc."
filed_at: "2023-08-21T23:59:59+00:00"
generated_at: "2026-06-11T05:57:16.780072+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Eloxx posts updated corporate presentation; no new specifics disclosed

## Summary
- Presentation posted on investors section of company website on August 21, 2023.
- No financial data, pipeline updates, or strategic changes included in the filing.
- Presentation title: 'RARE Thinking for RARE Solutions, Small Molecule Gene Therapy'.
- No forward-looking guidance or material changes from prior disclosures.

## SEC filing metadata
- accession: 0001104659-23-093964
- form_type: 8-K
- ticker: ELOX
- cik: 0001035354
- company_name: Eloxx Pharmaceuticals, Inc.
- filed_at: 2023-08-21T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1035354/000110465923093964/0001104659-23-093964-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1035354/000110465923093964/tm2324257d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-093964
- JSON: https://secwatch.observer/filing/0001104659-23-093964.json
- Plain text: https://secwatch.observer/filing/0001104659-23-093964.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.